These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9566702)

  • 1. Uptake of suramin by human microvascular endothelial cells.
    Gagliardi AR; Taylor MF; Collins DC
    Cancer Lett; 1998 Mar; 125(1-2):97-102. PubMed ID: 9566702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-localization of suramin and serum albumin in lysosomes of suramin-treated human colon cancer cells.
    Baghdiguian S; Boudier JA; Boudier JL; Fantini J
    Cancer Lett; 1996 Mar; 101(2):179-84. PubMed ID: 8620467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular localisation of suramin, an anticancer drug, in human colon adenocarcinoma cells: a study by quantitative autoradiography.
    Baghdiguian S; Boudier JL; Boudier JA; Fantini J
    Eur J Cancer; 1996 Mar; 32A(3):525-32. PubMed ID: 8814702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules.
    Schnitzer JE; Oh P; Pinney E; Allard J
    J Cell Biol; 1994 Dec; 127(5):1217-32. PubMed ID: 7525606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface binding and cellular internalization properties of suramin, a novel antineoplastic agent.
    Stein CA; Khan TM; Khaled Z; Tonkinson JL
    Clin Cancer Res; 1995 May; 1(5):509-17. PubMed ID: 9816010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for vesicles that mediate long-chain fatty acid uptake by human microvascular endothelial cells.
    Ring A; Pohl J; Völkl A; Stremmel W
    J Lipid Res; 2002 Dec; 43(12):2095-104. PubMed ID: 12454271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of an absorption phase after short intravenous suramin infusions.
    Hutson PR; Tutsch K; Spriggs D; Christian M; Rago R; Mutch R; Wilding G
    Cancer Chemother Pharmacol; 1993; 31(6):495-9. PubMed ID: 8453691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action.
    Waltenberger J; Mayr U; Frank H; Hombach V
    J Mol Cell Cardiol; 1996 Jul; 28(7):1523-9. PubMed ID: 8841939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibitory effects of suramin on HIV-1 are attenuated in the presence of albumin.
    Yao XJ; Wainberg MA; Pollak M
    AIDS; 1991 Nov; 5(11):1389-91. PubMed ID: 1768390
    [No Abstract]   [Full Text] [Related]  

  • 10. Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane.
    Danesi R; Del Bianchi S; Soldani P; Campagni A; La Rocca RV; Myers CE; Paparelli A; Del Tacca M
    Br J Cancer; 1993 Nov; 68(5):932-8. PubMed ID: 7692920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic localization of tritiated suramin in polarized human colon adenocarcinoma cells.
    Baghdiguian S; Boudier JA; Boudier JL; Fantini J
    Cancer Lett; 1993 Dec; 75(3):151-6. PubMed ID: 8313350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma.
    Ord JJ; Streeter E; Jones A; Le Monnier K; Cranston D; Crew J; Joel SP; Rogers MA; Banks RE; Roberts IS; Harris AL
    Br J Cancer; 2005 Jun; 92(12):2140-7. PubMed ID: 15928663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a human microvascular endothelial cell line as a model system to evaluate cholesterol uptake.
    Pruckler JM; Lawley TJ; Ades EW
    Pathobiology; 1993; 61(5-6):283-7. PubMed ID: 8297494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-existence of P2Y-and PPADS-insensitive P2U-purinoceptors in endothelial cells from adrenal medulla.
    Mateo J; Miras-Portugal MT; Castro E
    Br J Pharmacol; 1996 Nov; 119(6):1223-32. PubMed ID: 8937727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of [14C]suramin in tissues of male rats following a single intravenous dose.
    McNally WP; DeHart PD; Lathia C; Whitfield LR
    Life Sci; 2000 Sep; 67(15):1847-57. PubMed ID: 11043607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacometric analysis of the effect of furosemide on suramin pharmacokinetics.
    Piscitelli SC; Forrest A; Lush RM; Ryan N; Whitfield LR; Figg WD
    Pharmacotherapy; 1997; 17(3):431-7. PubMed ID: 9165547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer.
    John TA; Vogel SM; Tiruppathi C; Malik AB; Minshall RD
    Am J Physiol Lung Cell Mol Physiol; 2003 Jan; 284(1):L187-96. PubMed ID: 12471015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of serum and plasma albumin on intracellular Ca2+ in human endothelial cells.
    Fuentes E; Nadal A; Jacob R; McNaughton P
    J Physiol; 1997 Oct; 504 ( Pt 2)(Pt 2):315-26. PubMed ID: 9365906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of schedule, protein binding and growth factors on the activity of suramin.
    Lopez Lopez R; Peters GJ; van Loenen AC; Pizao PE; van Rijswijk RE; Wagstaff J; Pinedo HM
    Int J Cancer; 1992 Jul; 51(6):921-6. PubMed ID: 1639540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal clearance, tissue distribution, and CA-125 responses in a phase I trial of suramin.
    Hutson PR; Tutsch KD; Rago R; Arzoomanian R; Alberti D; Pomplun M; Church D; Marnocha R; Cheng AL; Kehrli N; Wilding G
    Clin Cancer Res; 1998 Jun; 4(6):1429-36. PubMed ID: 9626459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.